跳至主要内容
临床试验/IRCT2016013112592N3
IRCT2016013112592N3已完成2 期

The Effect of Adding Intravenous Midazolam to Apotel®in Treatment of Patients with Primary Headache Referred to Emergency Department

Tabriz University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • inclusion criteria: All 18-65 years old patients with primary headache (Migraine or tension).
  • Exclusion criteria: Sensitivity to used medicine, secondary type headache, vomiting, pregnancy, loss of consciousness, hepatic failure, breast-feeding, renal failure, psychotic disorder, get a medicine before arriving to emergency ward, dissatisfaction to participate to study.

排除标准

  • 未提供

研究者

相似试验

Effect of adding sedative agent to analgesics for... | 临床试验